Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BICALUTAMIDE Cause Deep vein thrombosis? 13 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Deep vein thrombosis have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 0.3% of all adverse event reports for BICALUTAMIDE.

13
Reports of Deep vein thrombosis with BICALUTAMIDE
0.3%
of all BICALUTAMIDE reports
0
Deaths
7
Hospitalizations

How Dangerous Is Deep vein thrombosis From BICALUTAMIDE?

Of the 13 reports, 7 (53.8%) required hospitalization, and 2 (15.4%) were considered life-threatening.

Is Deep vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does BICALUTAMIDE Cause?

Malignant neoplasm progression (352) Prostatic specific antigen increased (322) Drug ineffective (268) Fatigue (258) Prostate cancer (258) Asthenia (223) Hot flush (219) Off label use (171) Disease progression (169) Anaemia (164)

What Other Drugs Cause Deep vein thrombosis?

LENALIDOMIDE (3,286) RIVAROXABAN (3,180) TESTOSTERONE (2,213) APIXABAN (1,944) ETHINYL ESTRADIOL\ETONOGESTREL (1,577) RITUXIMAB (1,287) METHOTREXATE (1,146) DROSPIRENONE\ETHINYL ESTRADIOL (1,139) DEXAMETHASONE (1,067) ADALIMUMAB (1,056)

Which BICALUTAMIDE Alternatives Have Lower Deep vein thrombosis Risk?

BICALUTAMIDE vs BICTEGRAVIR BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BICALUTAMIDE vs BILASTINE

Related Pages

BICALUTAMIDE Full Profile All Deep vein thrombosis Reports All Drugs Causing Deep vein thrombosis BICALUTAMIDE Demographics